87 studies found for:    Open Studies | "Salivary Gland Diseases"
Show Display Options
Rank Status Study
21 Recruiting Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer
Condition: Radiation-Induced Xerostomia
Interventions: Other: Standard Oral Hygiene;   Other: Standard Oral Hygiene + True Acupuncture;   Other: Standard Oral Hygiene + Sham Acupuncture
22 Recruiting Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors
Conditions: Carcinoma, Non-Small-Cell Lung;   Thyroid Neoplasms;   Sarcoma;   Colorectal Neoplasms;   Salivary Gland Neoplasms;   Biliary Tract Neoplasms;   Brain Neoplasm, Primary;   Carcinoma, Ductal, Breast;   Melanoma;   Solid Tumors;   Glioblastoma;   Bile Duct Neoplasms;   Astrocytoma;   Head and Neck Squamous Cell Carcinoma;   Pontine Glioma
Intervention: Drug: LOXO-101
23 Recruiting Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery
Conditions: Head and Neck Squamous Cell Carcinoma;   Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Recurrent Nasopharynx Carcinoma;   Recurrent Salivary Gland Carcinoma;   Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary;   Stage III Major Salivary Gland Carcinoma;   Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage III Nasopharyngeal Carcinoma;   Stage IV Nasopharyngeal Carcinoma;   Stage IVA Major Salivary Gland Carcinoma;   Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVB Major Salivary Gland Carcinoma;   Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage IVC Major Salivary Gland Carcinoma;   Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Biological: Pembrolizumab;   Drug: Vorinostat
24 Recruiting Post-parotidectomy Facial Paresis: Intraoperative and Postoperative Factors
Conditions: Parotid Neoplasms;   Facial Paralysis
Intervention: Behavioral: Facial exercises
25 Recruiting A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Condition: Dry Eye With Sjögren's Syndrome
Interventions: Drug: KCT-0809 ophthalmic solution;   Drug: Placebo
26 Recruiting An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Condition: Dry Eye With Sjögren's Syndrome
Intervention: Drug: KCT-0809 ophthalmic solution
27 Recruiting A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome
Condition: Dry Eye With Sjögren's Syndrome
Intervention: Drug: KCT-0809 ophthalmic solution
28 Recruiting Acupuncture-Like Transcutaneous Electrical Nerve Stimulation in Treating Radiation-Induced Xerostomia in Patients With Head and Neck Cancer
Conditions: Head and Neck Carcinoma;   Xerostomia
Interventions: Other: Quality-of-Life Assessment;   Procedure: Transcutaneous Acupoint Electrical Stimulation
29 Recruiting A Phase II Study With Low-dose Recombinant Human IL-2 for the Treatment of Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: hrIL-2 active;   Drug: hrIL-2 placebo
30 Recruiting Pregnancy and Medically Assisted Conception in Rare Diseases
Conditions: Rheumatoid Arthritis;   Spondyloarthritis;   Psoriatic Arthritis;   Systemic Lupus Erythematosus;   Antiphospholipid Syndrome;   Sjogren Syndrome;   Scleroderma;   Myositis;   Vasculitis;   Mastocytosis;   Various Autoimmune and/or Systemic and/or Rare Diseases
Intervention:
31 Not yet recruiting Safety of a Single Administration of AAV2hAQP1, an Adeno-Associated Viral Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in People With Irradiation-Induced Parotid Salivary Hypofunction
Conditions: Squamous Cell Head and Neck Cancer;   Radiation Induced Xerostomia;   Salivary Hypofunction
Intervention: Biological: AAV2hAQP1
32 Recruiting Sjögren's Biomarker Study
Conditions: Healthy;   Sjögren's Syndrome
Intervention:
33 Not yet recruiting Investigating the Role of Mucin and Mucin Glycosylating Enzymes in Nasopharyngeal Carcinoma and Salivary Gland Cancer and Their Correlation With Clinical Prognosis
Conditions: Salivary Gland Cancer;   Nasopharyngeal Carcinoma
Intervention:
34 Not yet recruiting Study of Glycopyrrolate for Moderate-to-severe Sialorrhea in Parkinson's Disease
Conditions: Sialorrhea;   Parkinson's Disease
Interventions: Drug: Glycopyrrolate;   Drug: Placebo
35 Not yet recruiting the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients
Condition: Primary Sjogren Syndrome With Multisystem Involvement
Intervention: Other: Retrospective study
36 Recruiting Effect of Childhood Radioiodine Therapy on Salivary Function
Conditions: Xerostomia;   Hyperthyroidism;   Thyroid Cancer
Intervention: Other: Radioiodine
37 Not yet recruiting Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome
Condition: Sjogren's Syndrome
Interventions: Drug: Cyclosporin A;   Drug: Prednisone;   Drug: Placebo;   Drug: Calcium carbonate D
38 Recruiting A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Biological: AMG 557/MEDI5872;   Other: Placebo
39 Recruiting Feasibility Study of MRI Imaging on Parotid Gland Stimulation
Condition: Parotid Neoplasms
Interventions: Device: MRI;   Other: Citric acid;   Other: Gadovist
40 Recruiting Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Primary Sjögren's Syndrome
Condition: Primary Sjögren's Syndrome
Interventions: Drug: CFZ533 active - Cohort 1;   Drug: CFZ533 placebo- Cohort 1;   Drug: CFZ533 active - Cohort 2;   Drug: CFZ533 placebo - Cohort 2

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years